×
News Home

Should You Buy Theravance Biopharma Inc (TBPH) Stock After it Is Down 2.89% in a Week?

Tuesday, June 22, 2021 02:51 PM | InvestorsObserver Analysts
Should You Buy Theravance Biopharma Inc (TBPH) Stock After it Is Down 2.89% in a Week?

Theravance Biopharma Inc (TBPH) stock has fallen 2.89% over the past week and gets a Bearish rating from InvestorsObserver's Sentiment Indicator.

Sentiment Score - ,bearish
Theravance Biopharma Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on TBPH!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company.

Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive.

InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend.

Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With TBPH Stock Today?

Theravance Biopharma Inc (TBPH) stock is down -0.4% while the S&P 500 is higher by 0.42% as of 2:34 PM on Tuesday, Jun 22. TBPH is down -$0.07 from the previous closing price of $17.56 on volume of 141,668 shares. Over the past year the S&P 500 is higher by 36.07% while TBPH is down -21.78%. TBPH lost -$4.32 per share in the over the last 12 months.

To screen for more stocks like Theravance Biopharma Inc click here.

More About Theravance Biopharma Inc

Theravance Biopharma is a diversified biotechnology company that creates medicines to treat serious illnesses. The company's research and development are concentrated primarily on four therapeutic areas-infectious disease, respiratory, gastrointestinal disease, and cardiovascular and renal disease. Its commercial infrastructure is focused primarily on the acute care setting. The company uses strategic collaboration with other industry players. Theravance generates the majority of its revenue in the U.S. and Europe, followed by Asia.

Click Here to get the full Stock Score Report on Theravance Biopharma Inc (TBPH) Stock.

You May Also Like